Biofil Chemicals & Pharmaceuticals logo

Biofil Chemicals & Pharmaceuticals financials and balance sheet

NSE: BIOFILCHEMBSE: 524396Pharmaceuticals & BiotechnologySmall Cap

Last close ₹28.86down ₹0.18 (0.62%)BSE ₹28.17

Share price at the NSE close on 23 Oct 2026. Previous close ₹29.04.

52-week range of traded prices to 23 Oct 2026
₹25.60Low, 30 Mar 2026₹46.34High, 3 Feb 2026
Market cap
₹47 Cr3,363rd largest listed
P/E
97.0
P/B
2.2
Dividend yield
Nonein the last 12 months
ROE
2.4%
ROCE
2.1%
Debt to equity
0.14
Volume, NSE
3,19251.9% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Biofil Chemicals & Pharmaceuticals annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹40 Cr, year to Mar 2024

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue28
  2. Materials and goods−26
  3. Employee costs−0.8
  4. Other expenses−1.0
  5. Operating profit0.6
  6. Depreciation−0.3
  7. Other income+3.1
  8. One-off items0.0
  9. Finance costs0.0
  10. Profit before tax3.4
  11. Tax−0.7
  12. Net profit2.8

What the company owns

  • Receivables₹28 Cr
  • Plant, investments and other assets₹8 Cr
  • Inventory₹4 Cr
  • Cash and bank₹3 Cr

What pays for it: net worth and liabilities

  • Net worth₹22 Cr
  • Owed to suppliers₹17 Cr
  • Borrowings₹3 Cr
  • Other liabilities₹1 Cr

Biofil Chemicals & Pharmaceuticals business segments, year to Mar 2026

A reportable segment is a line of business the company must report on its own. Standalone, ₹ crore, as the company reports them.Biofil Chemicals & Pharmaceuticals segment results by quarter

Revenue by segment

₹28 CrTotal
  • Pharma Division₹19.0 Cr66.8% of total
  • Chemical Division₹9.4 Cr33.2% of total

Profit by segment

  • Pharma Division₹2.36 Cr71.4% of total
  • Chemical Division₹0.95 Cr28.6% of total

Segment results by year

Standalone, ₹ crore, years to March.

  • Pharma Division

    Revenue, ₹ crore
    Profit, ₹ crore
  • Chemical Division

    Revenue, ₹ crore
    Profit, ₹ crore
₹ croreMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue of all businesses23.229.936.622.530.040.033.428.4
Company revenue, as in its results23.129.735.822.430.040.033.428.4
Revenue21.124.427.019.024.227.926.719.0
Revenue growth–15.5%10.8%−29.6%27.3%15.2%−4.3%−28.9%
Profit0.60.91.21.0−0.10.0−0.12.4
Profit growth–43.9%28.3%−15.8%––––
Margin3.0%3.8%4.3%5.2%−0.6%0.0%−0.5%12.4%
Return on capital10.3%14.9%21.6%16.7%−2.6%0.3%−2.6%26.6%
Assets14.130.221.66.817.123.534.721.6
Liabilities7.924.016.20.911.419.829.212.7
Capital employed6.26.15.45.95.63.75.58.9
Revenue2.05.38.83.45.812.26.79.4
Revenue0.10.20.80.2––––
0.00.00.0–––––
Profit is before tax and finance costs, the way companies report their segments.

Profit and loss

Standalone, ₹ crore, years to March.Biofil Chemicals & Pharmaceuticals quarterly results

₹ croreMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 4 JulMar 2021Filed 8 JulMar 2022Filed 15 JunMar 2023Filed 31 MayMar 2024Filed 11 JulMar 2025Filed 13 JunMar 2026Filed 30 May
Revenue from operations13.512.423.129.735.822.430.040.033.428.4
10.811.422.127.934.221.028.939.232.627.7
Materials and goods bought8.59.820.025.332.419.527.437.530.826.0
Employee costs0.50.70.90.90.80.80.60.70.80.8
Other expenses1.80.91.21.71.00.80.81.00.91.0
Operating profit before depreciation2.60.91.01.81.61.31.20.80.80.6
Operating margin19.6%7.6%4.4%6.1%4.5%6.0%3.9%2.0%2.5%2.3%
Materials, % of revenue63.2%79.1%86.4%85.2%90.7%86.9%91.3%93.7%92.3%91.4%
Employee costs, % of revenue3.9%5.9%3.9%2.9%2.1%3.5%2.1%1.7%2.4%2.8%
Other expenses, % of revenue13.3%7.5%5.3%5.7%2.7%3.6%2.7%2.6%2.8%3.5%
Depreciation and amortisation0.30.30.40.40.40.40.40.40.40.3
Operating profit after depreciation2.40.60.71.41.20.90.70.40.50.4
Other income0.10.10.10.20.80.20.10.50.33.1
Finance costs0.20.20.20.10.10.00.00.00.00.0
Profit before one-off items and tax2.30.60.61.51.91.00.80.90.73.4
One-off items0.0–0.00.00.00.00.00.00.00.0
Profit before tax2.30.60.61.51.91.00.80.90.73.4
0.50.10.10.30.70.30.20.20.20.7
Net profit1.80.50.51.21.20.70.60.70.62.8
Other comprehensive income––0.00.00.00.0−0.10.20.00.0
Total comprehensive income––0.51.21.30.70.50.90.62.8
Net margin13.3%3.8%2.1%4.1%3.5%3.1%1.9%1.8%1.7%9.8%

Balance sheet

Standalone, ₹ crore, at 31 March.

₹ croreMar 2019Filed 12 JunMar 2020Filed 4 JulMar 2021Filed 8 JulMar 2022Filed 15 JunMar 2023Filed 31 MayMar 2024Filed 11 JulMar 2025Filed 13 JunMar 2026Filed 30 May
13.614.916.116.817.318.218.821.6
Share capital16.316.316.316.316.316.316.316.3
Reserves−2.6−1.4−0.10.61.01.92.55.3
Borrowings1.61.20.40.50.50.40.53.0
10.627.516.81.513.728.531.820.7
0.00.00.40.40.40.40.30.6
Total assets24.242.433.218.731.447.151.042.8
10.310.19.89.49.08.78.47.0
13.932.323.59.322.438.442.635.9
Net debt1.50.90.00.30.5−1.80.2−0.3
Borrowings are counted again inside the liabilities due within a year and after a year. No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March.

₹ croreMar 2021Filed 8 JulMar 2022Filed 15 JunMar 2023Filed 31 MayMar 2024Filed 11 JulMar 2025Filed 13 JunMar 2026Filed 30 May
1.1−0.2−0.12.4−1.9−0.6
1.1−0.20.12.5−1.70.1
−1.3−1.7−1.01.1−2.9−3.7
Receivables12.510.0−13.3−12.5−5.310.7
Inventories−2.73.10.1−1.3−0.8−0.7
Payables−10.1−15.312.114.93.4−13.9
Other working capital−1.10.40.10.0−0.30.2
Tax paid0.00.0−0.2−0.2−0.2−0.7
Capital spending0.60.10.00.00.10.2
Free cash flow0.5−0.3−0.12.4−2.0−0.8
−0.1−0.10.00.0−0.11.1
−0.80.00.0−0.10.02.5
Dividends paid0.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.0
Shares issued0.00.00.00.00.00.0
Net change in cash0.2−0.3−0.12.2−2.03.1
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018, Mar 2019 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 4 JulMar 2021Filed 8 JulMar 2022Filed 15 JunMar 2023Filed 31 MayMar 2024Filed 11 JulMar 2025Filed 13 JunMar 2026Filed 30 May
Earnings per share₹1.10₹0.29₹0.30₹0.76₹0.76₹0.44₹0.29₹0.44₹0.34₹1.71
Diluted earnings per share₹1.10₹0.29₹0.30₹0.76₹0.76₹0.44₹0.29₹0.44₹0.34₹1.71
Book value per share––₹8.39₹9.15₹9.91₹10.35₹10.63₹11.19₹11.54₹13.25
Shareholder yield––––0.0%0.0%0.0%0.0%0.0%0.0%
Market cap at the year end (₹ crore)–2311121079467996742
RatioMar 2017Mar 2018Mar 2019Filed 12 JunMar 2020Filed 4 JulMar 2021Filed 8 JulMar 2022Filed 15 JunMar 2023Filed 31 MayMar 2024Filed 11 JulMar 2025Filed 13 JunMar 2026Filed 30 May
Revenue growth–−8.3%87.1%28.4%20.4%−37.4%34.2%33.3%−16.6%−15.0%
Operating profit growth–−64.7%9.5%78.3%−12.3%−16.7%−12.4%−30.1%3.8%−23.4%
Net profit growth–−73.7%2.4%150.3%3.2%−43.9%−19.8%26.6%−21.4%399.4%
Earnings per share growth–−73.6%3.4%153.3%0.0%−42.1%−34.1%51.7%−22.7%402.9%
––3.5%8.5%8.0%4.2%3.3%4.0%3.0%13.8%
–––4.9 pts−0.4 pts−3.8 pts−1.0 pts0.7 pts−1.0 pts10.8 pts
From the net margin–––3.4 pts−1.2 pts−0.8 pts−1.7 pts−0.2 pts−0.2 pts14.7 pts
From asset turnover–––−0.5 pts0.4 pts−0.6 pts1.0 pts−0.5 pts−1.3 pts−2.0 pts
From borrowing–––2.0 pts0.3 pts−2.3 pts−0.2 pts1.3 pts0.5 pts−1.9 pts
Return on capital employed––4.3%8.8%7.2%5.2%4.1%2.2%2.4%1.5%
Cash conversion––––88.9%−31.5%−20.0%337.5%−344.9%−21.7%
Interest cover14.44.24.111.617.422.317.410.112.737.4
Debt to equity––0.120.080.030.030.030.020.030.14
Receivable days––190365176117249301419355
Inventory days––2224492416254056
Payable days––15737617811168268367240
Cash conversion cycle, days––551446130975892171
Working capital days––77706813311173119191
Asset turnover––0.960.890.950.861.201.020.680.61
Assets per rupee of net worth––1.772.332.441.581.472.212.652.33
Sales per rupee of plant––2.252.943.662.383.344.644.004.09
Capital spending to depreciation––––1.380.160.020.060.260.74
Plant being built, % of plant in use––0.0%–0.0%–––––
No balance sheet is on record for the years to Mar 2017 and Mar 2018, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
5.9%
Cash from operations against operating profit
−93.1%
Measure10 years5 years3 years
Revenue growth, yearly rate–−4.5%−1.9%
Profit growth, yearly rate–17.5%70.7%
Return on equity, average–5.7%6.9%
Return on capital employed, average–3.1%2.1%
Operating margin, average5.9%3.3%2.3%
Net margin, average4.5%3.6%4.4%
Asset turnover, average–0.870.77
Cash conversion cycle, days, average–109107
Interest cover, average15.120.020.0
Debt to equity, average–0.050.06

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations−0.47−0.13−0.60
Cash from investing0.931.011.14
Cash from financing2.422.412.54
Capital spending0.400.320.20
Dividends paid0.000.000.00
Shares bought back0.000.000.00
Shares issued for cash0.000.000.00
Borrowings raised2.672.582.55
Borrowings repaid0.080.080.00

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Piotroski score, out of 9Published threshold 3 points out of 9––––444435
Altman Z-scorePublished threshold 1.81––1.721.185.2731.644.293.272.282.71
Beneish M-scorePublished threshold −1.78––––––––−2.12−2.44
Profit not backed by cash, % of assetsPublished threshold 10 per cent of average total assets––––0.623.802.72−4.235.274.80
Cash from operations to profit, 3 yearsPublished threshold 0.7 times––––––0.311.050.20−0.03
Receivables growth less revenue growthOur threshold 0 percentage points–––118.69−62.46−20.94151.6127.8032.57−13.01
Inventory growth less cost-of-goods growthOur threshold 0 percentage points–––15.49128.63−30.25−47.0973.3648.8135.54
Other current assets growth less revenue growthOur threshold 5 per cent of revenue–––0.162.36−3.38−0.17−0.260.291.09
Assets under construction, years of additionsOur threshold 2 years of additions––––0.00–––––
Effective tax ratePublished threshold 17.16 per cent21.8020.0719.3917.5535.2331.1929.3318.0424.2219.24
Tax charged less tax paid, % of profitOur threshold 10 percentage points–––––31.190.33−9.700.000.00
A threshold marked as ours has no published figure; it is the line we read the check against.